Gel-E

About:

developed an advanced wound care platform designed to be used across a broad spectrum of clinical.

Top Investors: National Science Foundation, New York Angels, Robin Hood Ventures, Dingman Center for Entrepreneurship

Description:

gel-e Life Sciences has developed an advanced wound care platform that can be used across a broad spectrum of clinical and non-clinical settings. By making molecular modifications to natural biopolymers, gel-e’s patented approach provides rapid hemostasis in a clean, safe healing environment. Using non-dilutive grant funding, the company has achieved milestones such as 1 FDA Clearance, 5 issued patents, and 6 peer-reviewed publications.

Total Funding Amount:

$4.08M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

College Park, Maryland, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)gel-e.co

Founders:

Matthew Dowling

Number of Employees:

11-50

Last Funding Date:

2017-07-13

IPO Status:

Private

Industries: